Clinical Trial Update: Metabolic Effects of Antipsychotics in Children [Phase 4]

View source ↗

Summary

Phase 4 pediatric trial evaluating the metabolic effects of antipsychotics; results have been posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder
• Bipolar Disorder
• Oppositional Defiant Disorder

Snippet

Sponsor: Washington University School of Medicine | Conditions: Aggression, Attention Deficit-Hyperactivity | Phase 4 | Status: COMPLETED | Results posted: 2018-06-15